Thursday, 27 June 2013
5-Alpha Reductase Inhibitors Not Associated with Increased Risk for High-Grade Prostate ca
Men who take the 5-alpha reductase inhibitors (5-ARIs), finasteride and dutasteride, for lower urinary tract symptoms are not at increased risk for high-grade prostate tumors, according to a BMJ study. Since 2011, 5-ARI labels have warned of the increased risk for high-grade prostate cancer. - See more at:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment